How Ending Affirmative Action May Affect Radiation Oncology Workforce and Our Patients: A Collaboration of the American Society of Radiation Oncology, Society of Chairs of Academic Radiation Oncology Programs, Association for Directors of Radiation Oncology Programs, and Association of Residents in Radiation Oncology.
Michael C LeCompte, Iris C Gibbs, Kekoa Taparra, Gita Suneja, Curtiland Deville, Zachary White, Emily MacDuffie, Chelsea C Pinnix, Mitchell Kamrava, Rachel B Jimenez, Adam D Currey, Yuhchyau Chen, Idalid Franco
Author Information
- Michael C LeCompte: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland. Electronic address: mlecomp2@jhmi.edu.
- Iris C Gibbs: Department of Radiation Oncology, Stanford University, Palo Alto, California.
- Kekoa Taparra: Department of Radiation Oncology, Stanford University, Palo Alto, California.
- Gita Suneja: Department of Radiation Oncology, University of Utah, Salt Lake City, Utah.
- Curtiland Deville: Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
- Zachary White: Department of Radiation Oncology, Stanford University, Palo Alto, California.
- Emily MacDuffie: Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
- Chelsea C Pinnix: Department of Radiation Oncology, University of Texas MD Anderson Cancer, Houston, Texas.
- Mitchell Kamrava: Department of Radiation Oncology, Cedars Sinai Medical Center, Los Angeles, California.
- Rachel B Jimenez: Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
- Adam D Currey: Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
- Yuhchyau Chen: Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York.
- Idalid Franco: Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
No abstract text available.
